Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
Authors:
- Uwe WollinaUwe Wollina
- Gesina HanselGHGesina Hansel
- André KochAKAndré Koch
- Jaqueline SchönlebeJSJaqueline Schönlebe
- Erich KöstlerEKErich Köstler
- Gunter HaroskeGunter Haroske
- 1 January 2008
- journal article
- case report
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 9 (1) , 1-14
Abstract
F1000Prime Recommended Article: Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.Keywords
This publication has 44 references indexed in Scilit:
- New therapies for rheumatoid arthritisClinical and Experimental Immunology, 2005
- TNF?? Inhibitors in the Treatment of Psoriasis and Psoriatic ArthritisBioDrugs, 2005
- InfliximabDermatologic Therapy, 2004
- Skin reaction to adalimumabArthritis & Rheumatism, 2004
- Psoriasiform Eruption Induced by InfliximabAnnals of Pharmacotherapy, 2004
- A Randomized Trial of Etanercept as Monotherapy for PsoriasisArchives of Dermatology, 2003
- Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?Annals of the Rheumatic Diseases, 2003
- Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s diseaseGastroenterology, 2003
- Clinical research helps elucidate the role of tumor necrosis factor-αin the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probesLupus, 2003
- Transmembrane Tumor Necrosis Factor (TNF)-α Inhibits Adipocyte Differentiation by Selectively Activating TNF Receptor 1Journal of Biological Chemistry, 1999